what is glp 1 and glp 2 Discovery, characterization, clinical development of the glucagon-like peptides Targeting GLP-1, GIP & GCG

In addition, it has been reported that the pro-inflammatory factor IL-1 induces ER stress-related apoptosis in cultured chondrocytes 14

Enhanced insulin signaling following weight loss has been associated with decreased circulating levels of pro-inflammatory cytokines, including IL-6, TNF-, and C-reactive protein, as well as improvements in endothelial and adipose tissue function ( In inflammatory arthritis, including PsA, improved insulin sensitivity has been independently associated with reduced disease activity and inflammatory burden, even after adjustment for changes in BMI ( Consistent with this concept, GLP-1RAs have been shown to directly modulate immune responses by reducing the secretion of key pro-inflammatory cytokines such as IL-6 and TNF-, which are central drivers of inflammation in both PsO and PsA ( 3.4 Early PsA and future research directions Despite the promising metabolic and immunomodulatory effects observed in PsO, the role of GLP-1RAs in PsA, particularly in its early stages, remains largely unexplored

Concentrate on activities with minimal impact to prevent excessive strain

It was used in a once-daily multiple ascending dose phase Ib clinical trial and a 41-day phase IIa trial in overweight and type 2 diabetic patients, and the general safety and tolerability of MEDI0382 were established, as was its placebo-corrected efficacy in reducing fasting blood glucose (1.7 mmol/L), postprandial glucose excursions following a mixed meal test (22.6% area under the curve 04 hours), body weight (2.1 kg), and liver fat (19.6%)

Conclusin La activacin dual de los receptores GLP-1 y GIP aborda mltiples defectos fisiopatolgicos presentes en la DM2, con un mecanismo de accin sinrgico y multimodal que trasciende el control glucmico convencional